Icon

EVOTAZ (nda206353)- (EQ 300MG BASE;150MG)

ATAZANAVIR SULFATE; COBICISTAT BRISTOL
EQ 300MG BASE;150MG
Yes No
2032-Oct-06 2017-Aug-27
None None
None No
EVOTAZ is a two-drug combination of atazanavir, a human immunodeficiency virus (HIV-1) protease inhibitor, and cobicistat, a CYP3A inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg.
0 1 0
Total Other Developers 1
Drugs with Suitability No
EQ 300MG BASE;150MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.